Articles tagged with Regenerative Medicine
The Wallenberg Institute for Regenerative Medicine (WIRM) at Karolinska Institutet will focus on pioneering research in the blood system and stem-cell therapy, aiming to treat diseases like diabetes, spinal injuries, and neurodegenerative conditions. The grant strengthens the institute's infrastructure with advanced technical equipment...
Researchers at Cedars-Sinai are studying the mechanisms of how human immune systems reject or accept transplanted brain stem cells. The team aims to develop new stem cell therapies for patients with ALS, Parkinson's disease and other neurological disorders.
Researchers from Louisiana Tech University are presenting their work on smart nanofilms for regenerative medicine at the 2010 Experimental Biology meeting. Their presentation highlights the first known application of a smart nanofilm sprayed directly on living tissue, showing promising results in wound healing and potential application...
A new multifunctional polymer material can rapidly neutralize both biological and chemical toxins, including bacteria, viruses, and nerve agents. The material has been shown to be effective in restoring enzyme activity after exposure to toxins.
Clive Svendsen's team develops specifically-engineered stem cells that stall nerve cell degeneration in ALS patients. The award will fund novel ex vivo gene therapy approaches to treat the disease.
Researchers found that male hormones can help vessels around the heart regenerate, potentially explaining why men experience worse heart attacks earlier in life. Androgen replacement therapy might one day be used to treat men at risk for heart disease.
Chinese researchers have become a leading contributor to peer-reviewed scientific literature on clock-reversing regenerative medicine, with over 1,100 publications in 2008. New regulations aim to improve patient safety and restore China's global reputation.
Researchers found that vitamin C accelerates gene expression changes and promotes efficient iPSC generation. The study suggests a simple way to improve iPSC production, which can be considered a reversal of the aging process at the cellular level.
Researchers have developed a novel method to generate functional hepatocytes for drug testing, offering an unlimited and reliable source of liver cells. The new technique uses induced pluripotent stem cell technology to create hepatocytes from adult skin cells, overcoming the limitations of primary human hepatocytes.
Researchers have successfully reprogrammed human umbilical cord blood cells into cells with properties similar to human embryonic stem cells. This breakthrough identifies cord blood as a potential alternative to adult cells for generating cells with theoretically limitless potential.
Bioengineers at UC San Diego have developed a novel method for sequencing-based methylation profiling, enabling more efficient and cost-effective methods for studying certain diseases. The breakthrough could fuel personalized regenerative medicine and help address concerns about stem cell tumors.
The University of Nottingham's studies found that improved collaboration with clinicians, better funding, and regulatory certainty are crucial for stem cell therapy success. The industry is at risk of market failure due to structural barriers within the NHS.
Dr. Nagy's method uses a novel wrapping procedure to deliver specific genes, overcoming major hurdles for personalized stem cell therapies. The breakthrough accelerates stem cell technology and provides a road map for new clinical approaches to regenerative medicine.
The University of California, San Francisco (UCSF) has received tentative approval for a comprehensive stem cell training program, designed to cultivate the next generation of stem cell scientists. The three-year grant, totaling $3.9 million, will support six graduate students, six postdoctoral fellows, and four clinician-scientists.
The study shows significantly increased disc tissue density and extracellular matrix components at 12 months post treatment, suggesting a potential link between ADRCs and improved disc condition. Viable ADRCs were identified within the discs, indicating a possible novel therapeutic for spinal surgery patients.
UC San Diego assistant bioengineering professor Karen Christman receives a $1.5 million NIH grant to further her research on developing novel multi-layer patterning technique for cell and tissue development. The goal is to control cell fate and generate differentiated cell sources, with potential applications in regenerative medicine.
Researchers have found that human umbilical cord blood cells can improve liver damage and function in rats with hepatitis. The study provides an alternative to bone marrow transplants for hepatic regenerative medicine, offering hope for patients suffering from terminal hepatic failure.
A cross-disciplinary research team from Harvard University, Whitehead Institute, and the Broad Institute of MIT and Harvard has uncovered significant new information about the molecular changes that underlie direct reprogramming. The researchers found that most cells fail to reprogram due to activation of normal 'fail safe' mechanisms.
The University of California, San Francisco has received a $34.9 million grant from the California Institute for Regenerative Medicine to construct a regenerative medicine building on its campus. The facility will house 25 principal investigators and their teams at full capacity, driving the cross-pollination of scientific ideas.
A Rutgers-led team has been awarded $42.5 million to create an Institute of Regenerative Medicine, focusing on regenerative medicine and biomaterials science to treat severe blast trauma. The institute aims to develop new therapies for the repair of battlefield injuries and serve civilian trauma patients.
Researchers at Rice and UT-Houston will lead a $2 million DOD-funded project to develop new tissue engineering technologies and novel reconstructive surgical techniques for facial reconstruction. The goal is to quickly grow large volumes of bone tissue to aid wounded soldiers.
The Armed Forces Institute of Regenerative Medicine (AFIRM) will focus on repairing battlefield injuries through regenerative medicine. Researchers aim to develop clinical therapies for burn repair, wound healing without scarring, craniofacial reconstruction, limb reconstruction, and treating compartment syndrome.
Research reveals that microRNA depletion is necessary for tissue regeneration and that manipulating certain microRNA levels can enhance regenerative success in zebrafish. By tweaking the FGF signaling pathway, scientists were able to increase or decrease specific microRNA levels, resulting in improved or inhibited fin regeneration.
A protein found in human hair, keratin, has been shown to speed up nerve regeneration and improve nerve function in animal studies. The study used keratin-filled gels to repair nerve gaps and showed promising results compared to current treatment options.
Researchers identified a regenerative process in the sea squirt that could be applied to humans, allowing damaged organs to repair themselves. This breakthrough has major implications for regenerative medicine, potentially treating conditions such as missing limbs and scarred hearts.
Scientists at Forsyth Institute successfully induced frog tadpole tail regeneration using gene therapy and electric fields. This breakthrough discovery may hold key to regenerating human spinal cord tissue, providing insights into the role of bioelectricity in regeneration.
Researchers have identified genes and signaling pathways that enable zebrafish to regrow their tail fins. The study suggests that humans may also have untapped regenerative powers hidden in their genes, potentially leading to new treatments for human injuries.
Regenerative medicine holds promise for affordable treatments and offsetting donor shortages, particularly for diabetes, heart disease, and infectious diseases. The study prioritizes 10 applications, including novel insulin replacement methods, regenerating failed heart muscle, and engineered immune cells.
A new study ranks the top applications of regenerative medicine for improving health in developing countries, including novel insulin replacement and pancreatic islet cell regeneration for diabetes. Regenerating failed heart muscle using a patient's own cells is also highly ranked.
Researchers at the University of Toronto have discovered bone marrow adult stem cells play a crucial role in repairing damaged hearts. The 'SOS' distress signal mobilizes these cells to stimulate new blood vessel growth and restore heart function.
A new technology developed by Pall Corporation enables faster and more efficient cell harvesting for cell therapy, with processing times reduced to under 15 minutes. The system exhibits higher yield of cells and is easy to use, adhering to Good Manufacturing Practice (cGMP) regulations.
Researchers have made significant breakthroughs in developing biohybrid lung devices, regenerative potential of stem cells, biomechanical training of tissue constructs, and artificial esophagus using extracellular matrix scaffolds. These advancements aim to restore function of damaged or diseased tissues and organs.
A Wake Forest physician has successfully grown functional bladder organs in patients with congenital defects, showing improved bladder function and reduced kidney damage over time. The lab-grown bladders eliminated the need for surgical repair with intestine tissue, offering a potential solution to organ shortages.
The Broad Institute will be a pivotal hub for integrative biomedical research, bringing together researchers and biologists in one place. The institute will support the development of novel platforms in imaging, bioengineering, and nanotechnology for stem cell research.
The FDA has approved the first medical device using a Rutgers-developed biomaterial for hernia repairs. The device features a partially degradable polymer that facilitates precise placement and reduces implant material following resorption. This approval represents a major breakthrough for regenerative medicine.
The university's new regenerative medicine program aims to translate basic stem cell science into therapies for degenerative diseases. The program will draw on faculty from five Medical School departments and be supported by $700,000 in annual funding.
Researchers are exploring new technologies to regenerate bone, enhance ligament healing, produce tissue-engineered cartilage and improve bone healing with stem cells derived from muscle. These advances hold promise for treating devastating congenital or traumatic problems and preventing degenerative processes in the aging population.
The Methuselah Foundation's M Prize has sparked public interest in regenerative biomedicine, with a focus on slowing and reversing aging. Researchers will compete for the most dramatic advances in lifespan extension and aging retardation using interventions initiated in middle age.
The National Center for Regenerative Medicine will enable groundbreaking research discoveries using non-embryonic stem cells to treat thousands of patients annually. The center's education programs will train personnel in performing innovative research and delivering world-class patient care.
Researchers at Northwestern University are using regenerative medicine to help paralyzed people walk again and enable diabetic individuals to lead normal lives without daily treatments or organ donations. The team is focusing on synthetic scaffolds and their interactions with cells, a key component of regenerative medicine.
Cleveland stem cell investigators Stanton Gerson, George Muschler, and Jaroslaw Maciejewski received grants to study the effects of aging on blood stem cells and optimize assays for human stem cells in bone marrow. Their research aims to improve understanding of age-related diseases such as anemia and cancer.
Researchers at the University of Toronto have created a new gel-like substance that guides neural cells through channels, providing a greater surface area for neural stimuli transmission. This breakthrough could lead to stronger signals in regenerated nerves, paving the way for regenerative medicine applications.
Researchers at the University of Pittsburgh's McGowan Institute for Regenerative Medicine have made significant strides in growing functioning liver tissue in a bioreactor, keeping patients with liver failure alive until donor organs become available. Additionally, studies on tissue-engineered materials show promise as a treatment for ...
Researchers at the University of Pittsburgh's McGowan Institute for Regenerative Medicine have made significant breakthroughs in regenerative medicine. Filtering antibodies from blood may decrease the risk of organ rejection, with experiments showing a 40-60% reduction when coated with specific antigens. Additionally, injecting drag-re...
Researchers at UNC School of Medicine are exploring the role of growth factors in axon regeneration, with a focus on improving spinal cord repair. They have identified a signal transduction mediator that promotes rapid axon growth and widening.